AQR Capital Management
PNT

AQR Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

AQR Capital Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-552,753
Closed -$3.69M – 2476
2023
Q3 		$3.69M Buy
552,753
+97
+0% +$806 0.01% 1056
2023
Q2 		$5.01M Buy
552,656
+542,148
+5,159% +$4.78M 0.01% 902
2023
Q1 		$76.4K Sell
10,508
-107
-1% -$794 ﹤0.01% 2129
2022
Q4 		$77.4K Buy
+10,615
New +$78.8K ﹤0.01% 2153

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

AQR Capital Management's PNT Position: Q4 2023 in Review

AQR Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 552,753 shares — an estimated $3.69M sold.

AQR Capital Management first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $5.01M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • AQR Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • AQR Capital Management sold 552,753 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $3.69M.
  • AQR Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • AQR Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $5.01M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.